Skip to content
NE

New Era Alkaloids And Export

530303 BSE
Price unavailable
View as Markdown
MCP

No trades in 1Y

Key Insights

Strengths

1
  • Company has reduced debt.

Weaknesses

1
  • Company has low interest coverage ratio.

Growth Rate

From the financial statements below. 10Y, 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Jun 2026 against Jun 2025.

Revenue

Revenue growth by window
10Y+15.87%
5YIrregular period
3YIrregular period
1Y−51.52%
TTM−75.53%

Net profit

Net profit growth by window
10YTurned to loss
5YIrregular period
3YIrregular period
1YLoss widened by ₹0.21 Cr
TTMLoss widened by ₹0.24 Cr

Operating margin· change in pp

Operating margin growth by window
10Y−5.49 pp
5YIrregular period
3YIrregular period
1Y−12.56 pp
TTM−38.07 pp

Revenue by year

Revenue by year, ₹ crore
Mar 2014₹1.16 Cr
Mar 2015₹0.28 Cr
Mar 2016₹0.11 Cr
Mar 2017₹0.04 Cr
Mar 2018₹1.83 Cr
Mar 2019₹1.08 Cr
Mar 2024₹0.00 Cr
Mar 2025₹0.99 Cr
Mar 2026₹0.48 Cr

Net profit by year

Net profit by year, ₹ crore
Mar 2014₹0.18 Cr
Mar 2015−₹0.23 Cr
Mar 2016₹0.08 Cr
Mar 2017−₹0.21 Cr
Mar 2018₹0.09 Cr
Mar 2019₹0.43 Cr
Mar 2024₹0.33 Cr
Mar 2025−₹0.02 Cr
Mar 2026−₹0.23 Cr

Quarterly Results

₹ Cr
530303 quarterly results, ₹ crore
Particulars Jun 2021Jun 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
0
0
0
0
0
0
0.44
0.25
0.25
0
0
0.23
0
Expenses
0.03
0.01
0.01
0.02
0.3
0.04
0.4
0.26
0.25
0.03
0.02
0.25
0.02
Operating Profit
−0.03
−0.01
−0.01
−0.02
−0.3
−0.04
0.04
−0.01
0
−0.03
−0.02
−0.02
−0.02
OPM %
—
—
—
—
—
—
9.09%
−4%
0%
—
—
−8.7%
—
Other Income
0.05
0.06
0.16
0.07
0.3
0
0
0.07
0
0
0
0.08
0
Interest
0
0
0
0
0
0
0
0
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
0
0
0
0
PBT
0.02
0.05
0.15
0.05
0
−0.04
0.04
0.06
0
−0.03
−0.02
0.06
−0.02
Tax %
−150%
0%
0%
0%
—
0%
175%
0%
—
0%
0%
400%
0%
Net Profit
0.05
0.05
0.15
0.05
0
−0.04
−0.03
0.06
0
−0.03
−0.02
−0.18
−0.02

Profit & Loss

₹ Cr
530303 profit and loss, annual, ₹ crore
Particulars Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2024Mar 2025Mar 2026TTM
Sales
1.16
0.28
0.11
0.04
1.83
1.08
0
0.99
0.48
0.23
Expenses
0.91
0.42
0.12
0.18
1.71
0.86
0.06
1.01
0.55
0.32
Operating Profit
0.25
−0.14
−0.01
−0.14
0.12
0.22
−0.06
−0.02
−0.07
−0.09
OPM %
21.55%
−50%
−9.09%
−350%
6.56%
20.37%
—
−2.02%
−14.58%
−39.13%
Other Income
0.09
0.01
0.09
0.06
0
0.38
0.39
0.07
0.08
0.08
Interest
0.03
0
0.01
0.05
0
0.01
0
0
0
0
Depreciation
0.13
0.13
0
0
0
0
0
0
0
0
PBT
0.18
−0.26
0.07
−0.13
0.12
0.59
0.33
0.05
0.01
−0.01
Tax %
0%
−11.54%
−28.57%
61.54%
16.67%
25.42%
0%
140%
2400%
—
Net Profit
0.18
−0.23
0.08
−0.21
0.09
0.43
0.33
−0.02
−0.23
−0.25
Div. Payout %
0%
0%
0%
0%
0%
0%
0%
0%
0%
—

Balance Sheet

₹ Cr
530303 balance sheet, annual, ₹ crore
Particulars Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2024Mar 2025Sep 2025
Equity Capital
3.28
3.28
3.28
3.28
3.28
3.28
3.28
3.28
3.28
Reserves
1.32
1.22
1.29
1.08
0.7
2.76
4.74
4.9
4.87
Borrowings
9.81
7.57
23.53
24.16
23.81
0.6
0
1.8
1.1
Other Liabilities
16.29
15.39
3.19
0.53
0.68
14.7
0.61
0.29
0.02
Total Liabilities
30.7
27.46
31.29
29.05
28.47
21.34
8.63
10.27
9.27
Fixed Assets
0.08
0.08
0.07
0.07
0.07
0.06
0
0
0
CWIP
0
0
0
0
0
0
0
0
0
Investments
5.36
8.41
8.41
8.41
6.04
7.66
2.13
2.42
2.31
Other Assets
25.26
18.97
22.81
20.57
22.36
13.62
6.5
7.85
6.96
Total Assets
30.7
27.46
31.29
29.05
28.47
21.34
8.63
10.27
9.27

Cash Flow

₹ Cr
530303 cash flow, annual, ₹ crore
Particulars Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2024Mar 2025Mar 2026
Operating
—
1.26
0.52
0
−2.67
9.05
−0.76
−1.75
—
Investing
—
0.97
−2.9
0
1.85
0
8.66
0
—
Financing
—
−2.26
2.43
0
−0.36
−9.09
−7.89
1.87
—
Net Cash Flow
—
−0.02
0.05
0
−1.18
−0.04
0.01
0.11
—
Free Cash Flow
—
1.26
0.52
0
−2.67
9.05
−0.76
−1.75
—
CFO/OP
—
−900
−5,200
0
−2,208
4,182
283
8,400
—

Ratios

530303 financial ratios, annual
Particulars Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2024Mar 2025Mar 2026
Debtor Days
909
1,147
2,455
0
269
0
—
55.3
—
Inventory Days
223
0
—
—
—
—
—
0
—
Days Payable
6,540
—
—
—
—
—
—
—
—
Cash Conversion Cycle
−5,407
1,147
2,455
0
269
0
—
55.3
—
Working Capital Days
−4,056
Not meaningful for this period: the ratio divides by a base close to zero, so it is left blank rather than shown as a very large number.
2,688
1,369
1,388
−4,106
—
107
—
ROCE %
—
−1.96%
0.4%
−0.28%
0.43%
3.49%
—
0.56%
—

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view New Era Alkaloids And Export insights

28 extracted metrics across FY14–FY27.

Shareholding Pattern

Not shown: Shareholding Pattern. Not this company's figures: left behind by an earlier update and not confirmed by the latest one.

Frequently Asked Questions about New Era Alkaloids And Export

Where is New Era Alkaloids And Export Ltd (530303) listed?
New Era Alkaloids And Export Ltd trades under code 530303 on the BSE.

Company Information

Face Value ₹10

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/530303.md for New Era Alkaloids And Export Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month